AOP Health Wins FDA Approval for Rapiblyk in Pediatric SVT
Wilmington, Delaware, U.S. | April 15, 2026 AOP Health US, LLC has achieved a significant regulatory milestone with the...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Wilmington, Delaware, U.S. | April 15, 2026 AOP Health US, LLC has achieved a significant regulatory milestone with the...
TEL AVIV, ISRAEL — December 8, 2025 — FIZE Medical announced the launch of its FIZE kUO® digital urine-output...
